1. A retrospective analysis from a single center for 60 COVID-19 patients with asymptomatic, mild to moderate, and severe conditions in Wuxi, China. Issue 30 (30th July 2021) Authors: Huang, Jiehui; Qian, Chao; Bian, Tao; Chu, Meiping; Yin, Weiwei; Pang, Yonghua; Bai, Jinmei; Huang, Yanjie Other Names: Li. Jinfeng section editor. Journal: Medicine Issue: Volume 100:Issue 30(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adverse event profiles of PCSK9 inhibitors alirocumab and evolocumab: Data mining of the FDA adverse event reporting system. Issue 12 (20th July 2022) Authors: Ji, Chunmei; Bai, Jinmei; Zhou, Jiancheng; Zou, Ying; Yu, Mingming Other Names: Wong Ian guestEditor.; Dewildt Saskia guestEditor. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 12(2022) Page Start: 5317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Amphiphilic diblock copolymer of hydrophilic-functionalized lactone and lactide via switchable organocatalytic polymerization. Issue 4 (9th January 2018) Authors: Bai, Jinmei; Tang, Xiaoying; Zhang, Yuan; Lin, Jingjing; Li, Minfeng Journal: RSC advances Issue: Volume 8:Issue 4(2018) Page Start: 1905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Amphiphilic diblock copolymer of hydrophilic-functionalized lactone and lactide via switchable organocatalytic polymerization. Issue 4 (9th January 2018) Authors: Bai, Jinmei; Tang, Xiaoying; Zhang, Yuan; Lin, Jingjing; Li, Minfeng Journal: RSC advances Issue: Volume 8:Issue 4(2018) Page Start: 1905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗